Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gene Therapy

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301465PMID 11420640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox

  2001cited by this paper
• Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing--remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide.

  2000cited by this paper
• Interferon β in multiple sclerosis: is IL-12 suppression the key?

  2000cited by this paper
• Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

  2000cited by this paper
• Interferon beta in multiple sclerosis: is IL-12 suppression the key?

  2000cited by this paper
• Time-Resolved Fluorometry PCR Assay for Rapid Detection of Herpes Simplex Virus in Cerebrospinal Fluid

  2000cited by this paper
• Development and Optimization of Herpes Simplex Virus Vectors for Multiple Long-Term Gene Delivery to the Peripheral Nervous System

  2000cited by this paper
• Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors

  2000cited by this paper
• Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

  2000cited by this paper
• Replication-competent herpes simplex viral vectors for cancer therapy.

  2000cited by this paper
• A novel and efficient regimen for producing chronic relapsing experimental autoimmune encephalomyelitis (CR‐EAE) in SJL mice

  1999cited by this paper
• Differential Influence of Interleukin-12 in the Pathogenesis of Autoimmune and Virus-Induced Central Nervous System Demyelination

  1999cited by this paper
• Prevention of Experimental Allergic Encephalomyelitis by Intramuscular Gene Transfer with Cytokine-Encoding Plasmid Vectors

  1999cited by this paper
• Nasal administration of transforming growth factor-β1 induces dendritic cells and inhibits protracted-relapsing experimental allergic encephalomyelitis

  1999cited by this paper
• Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis.

  1999cited by this paper
• Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice.

  1999cited by this paper
• Progress in determining the causes and treatment of multiple sclerosis

  1999cited by this paper
• Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.

  1998cited by this paper
• Cytokine gene expression in cells derived from CSF of multiple sclerosis patients.

  1998cited by this paper
• Reciprocal stimulation between TNF-alpha and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis.

  1998cited by this paper
• Central Nervous System Delivery of Interleukin 4 by a Nonreplicative Herpes Simplex Type 1 Viral Vector Ameliorates Autoimmune Demyelination

  1998cited by this paper
• [Experimental autoimmune encephalomyelitis].

  1998cited by this paper
• A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice.

  1998cited by this paper
• Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system.

  1998cited by this paper
• Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.

  1998cited by this paper
• Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-1-mediated Th1 differentiation; an effect of the novel anti-inflammatory drug lisofylline

  1998cited by this paper
• Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

  1998cited by this paper
• IL-4-Deficient C 57 BL / 6 Mice and BALB / c Mice Encephalomyelitis as Demonstrated in Severity in Experimental Allergic A Critical Role for IL-4 in Regulating Disease

  1998cited by this paper
• The pattern of cytokine gene expression in lymphoid organs and peripheral blood mononuclear cells of mice with experimental allergic encephalomyelitis.

  1998cited by this paper
• Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1.

  1997cited by this paper
• The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors.

  1996cited by this paper
• Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1.

  1996cited by this paper
• Physical state of the neuroantigen in adjuvant emulsions determines encephalitogenic status in the BALB/c mouse.

  1996cited by this paper
• Experimental Autoimmune Encephalomyelitis in the Rat

  1996cited by this paper
• Phenotypic properties of herpes simplex virus 1 containing a derepressed open reading frame P gene

  1996cited by this paper
• The regulation of synthesis and properties of the protein product of open reading frame P of the herpes simplex virus 1 genome

  1995cited by this paper
• Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1

  1995cited by this paper
• Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta.

  1995cited by this paper
• Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis

  1994cited by this paper
• Expression of a herpes simplex virus 1 open reading frame antisense to the gamma(1)34.5 gene and transcribed by an RNA 3' coterminal with the unspliced latency-associated transcript

  1994cited by this paper
• The T lymphocyte in experimental allergic encephalomyelitis.

  1990cited by this paper
• A method for the covalent attachment of cells to glass slides for use in immunohistochemical assays.

  1985cited by this paper
• Experimental allergic encephalomyelitis : a useful model for multiple sclerosis : a satellite conference of the International Society of Neurochemists held at the University of Washington, Seattle, Washington, July 16-19 1983

  1984cited by this paper
• Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?

  1984cited by this paper
• [Experimental allergic encephalomyelitis].

  1962cited by this paper

• Advanced progress in the genetic modification of the oncolytic HSV-1 virus

  2025cites this paper
• Is there a role for herpes simplex virus type 1 in multiple sclerosis?

  2022cites this paper
• A comparative study of experimental mouse models of central nervous system demyelination

  2014cites this paper
• "HSV‑1 has natural properties, which are favorable for therapy vectors: the life ‑ long latent form of infection in the nervous system, which could be exploited for long‑term transgene expression, and the episomal DNA genome…"

  2013cites this paper
• Herpes simplex virus type 1 (HSV-1) pathogenesis and HSV gene therapy of experimental autoimmune encephalomyelitis

  2013influential citation
• A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity

  2013cites this paper
• The virtues and vices of harnessing HSV vectors for CNS autoimmunity modulation.

  2013cites this paper
• Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception

  2012cites this paper
• Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5

  2011cites this paper
• T cells in Rheumatoid Arthritis

  2011cites this paper
• Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2

  2010cites this paper
• HSV Recombinant Vectors for Gene Therapy.

  2010cites this paper
• HSV Recombinant Vectors for Gene Therapy

  2010cites this paper
• Host responses to herpes simplex virus and herpes simplex virus vectors

  2010cites this paper
• Effect of intranasal administration of Semliki Forest virus recombinant particles expressing interferon-β on the progression of experimental autoimmune encephalomyelitis.

  2008cites this paper
• Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy.

  2006cites this paper
• Gene Therapy to the Nervous System

  2006cites this paper
• Cytokines and immune regulation in the nervous system

  2006cites this paper
• Adenovirus-mediated gene delivery of interleukin-10, but not transforming growth factor beta, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice.

  2005cites this paper
• HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy.

  2005cites this paper
• Gene Therapy Approaches for Autoimmune Diseases of the Central Nervous System and Other Tissues

  2005cites this paper
• Immune response to herpes simplex virus and gamma134.5 deleted HSV vectors.

  2005cites this paper
• GENE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS IN NZB/W F1 MICE

  2005influential citation
• The Neuron and Axon in Experimental Autoimmune Encephalomyelitis

  2005cites this paper
• Adenovirus‐mediated gene delivery of interleukin‐10, but not transforming growth factor β, ameliorates the induction of Graves’ hyperthyroidism in BALB/c mice

  2005cites this paper
• IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitis.

  2004cites this paper
• Gene therapy for autoimmune diseases.

  2004cites this paper
• Treatment of Experimental Autoimmune Encephalomyelitis with a Neurotropic Alphavirus Vector Expressing Tissue Inhibitor of Metalloproteinase‐2

  2004cites this paper
• Spread and Replication of and Immune Response to γ134.5-Negative Herpes Simplex Virus Type 1 Vectors in BALB/c Mice

  2004cites this paper
• Immunomodulation by roquinimex decreases the expression of IL‐23 (p19) mRNA in the brains of herpes simplex virus type 1 infected BALB/c mice

  2004cites this paper
• Low copy number detection of herpes simplex virus type 1 mRNA and mouse Th1 type cytokine mRNAs by Light Cycler quantitative real-time PCR.

  2003cites this paper
• Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.

  2003cites this paper
• Vectors for the treatment of autoimmune disease

  2003cites this paper
• Herpesviruses in brains in Alzheimer's and Parkinson's diseases

  2003cites this paper
• Gene therapy-mediated modulation of immune processes in the central nervous system.

  2003cites this paper
• Molecular and cellular basis for designing gene vaccines against inflammatory autoimmune disease.

  2003cites this paper
• Early‐onset Parkinson's disease caused by a compound heterozygous DJ‐1 mutation

  2003cites this paper
• Gene therapy in autoimmune, demyelinating disease of the central nervous system

  2003cites this paper
• The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system.

  2003cites this paper
• Interleukin-10 Therapy—Review of a New Approach

  2003cites this paper
• Herpes Simplex Virus Type 1 Infection Induces Upregulation of Interleukin-23 (p19) mRNA Expression in Trigeminal Ganglia of BALB/c Mice

  2002cites this paper
• CYTOKINES IN EXPERIMENTAL HERPES SIMPLEX VIRUS INFECTION

  2002cites this paper
• Differential Expression of Cytokines (IL‐2, IFN‐γ, IL‐10) and Adhesion Molecules (VCAM‐1, LFA‐1, CD44) Between Spleen and Lymph Nodes Associates with Remission in Chronic Relapsing Experimental Autoimmune Encephalomyelitis

  2002cites this paper